In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
Gary S. Cohen, MD, Chief, Vascular Interventional Radiology, Vice Chairman of Clinical Services, Professor of Radiology, Temple University School of Medicine, discusses a possible treatment for early stage…
There has been an ASCO 2007 update of recommendations for the use of tumor markers in breast cancer. References and Resources ASCO 2007 Update of Recommendations for the…
Gerard J. Criner, MD, Director/Professor of Medicine, Division of Pulmonary and Critical Care Medicine, Temple University School of Medicine, discusses research using combination therapy for treatment of chronic…
Gerard J. Criner, MD, Director/Professor of Medicine, Division of Pulmonary and Critical Care Medicine, Temple University School of Medicine, discusses a recent clinical trial with combination drug therapies…
The FDA clears a silver coated breathing tube (used for ventilation) for marketing. References and Resources FDA Clears Silver-Coated Breathing Tube for Marketing – Reduces Risk of Pneumonia…
New guideline recommendations for the use of anticoagulation in the prevention and treatment of venous thromboembolism in patients with cancer have been released. References and Resources Lyman G,…
The ACP has released its latest clinical practice guidelines for the diagnosis and treatment of COPD. References and Resources Qaseem A, Snow V, Shekelle P, et al. Diagnosis…
Robert Kravitz, MD, Medical Director, St. Francis Pain Center, Indianapolis IN, physiatrist and pain expert, discusses chronic pain management. References and Resources Cicero TJ, Inciardi JA, Munoz A:…
A recent study has found that cancer-specific survival of a patient can be predicted from previous parental survival from cancer at the same site. References and Resources Lindstrom…
The FDA announced that Trasylol increases risk of death, and therefore a marketing suspension has occurred. References and Resources FDA Requests Marketing Suspension of Trasylol Click Here to…
